[mkdf_section_title position=”” show_separator=”yes” separator_position=”center” title_tag=”” disable_break_words=”no” title=”Pubblicazioni 2014″ holder_padding=”13px”]

The coagulopathy of cancer.

Falanga A, Russo L, Milesi V.

Curr Opin Hematol. 2014;21(5):423-9.

7th international conference on thrombosis and hemostasis issues in cancer. Preface.

Falanga A, Brenner B, Rickles FR.

Thromb Res. 2014;133 Suppl 2:ix.

Thrombosis in myeloproliferative neoplasms.

Falanga A, Marchetti M.

Semin Thromb Hemost. 2014;40(3):348-58.

PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo.

Catucci I, Peterlongo P, Ciceri S, Colombo M, Pasquini G, Barile M, Bonanni B, Verderio P, Pizzamiglio S, Foglia C, Falanga A, Marchetti M, Galastri L, Bianchi T, Corna C, Ravagnani F, Bernard L, Fortuzzi S, Sardella D, Scuvera G, Peissel B, Manoukian S, Tondini C, Radice P.

Genet Med. 2014;16(9):688-94.

Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia.

Marchetti M, Tartari CJ, Russo L, Panova-Noeva M, Leuzzi A, Rambaldi A, Finazzi G, Woodhams B, Falanga A.

Am J Hematol. 2014;89(1):68-73.